Heads up. On Doximity app--for docs only--most docs posting are seeing good results with HCQ in mild disease exactly like Misiu says.

As discussed before the value of a control group is important. As is the fact that this disease is so variable. I am not sure, due to huge variability in patient outcomes, whether any drug which is not dramatically effective in most cases will clearly show benefit in a controlled trial. Just IMO